Skorochod R, Nesher R, Nesher G, et al. - Because botulinum toxin has found a place as a neuromuscular blocking agent in a variety of medical fields over the years, researchers conducted a literature search in PubMed and Cochrane Library databases for reported cases of ophthalmic adverse events following botulinum toxin facial injections. They discovered 25 publications that reported 49 cases of ophthalmic adverse events after botulinum toxin injections. Diplopia, ptosis, and a decrease in visual acuity or vision loss were among the side effects of the injections. Botulinum toxin is gaining popularity in the treatment of a wide range of diseases as well as for cosmetic purposes. In order to reduce complications, clinicians must have a thorough understanding of potential adverse events.